CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026Globe Newswire•08/09/2026•20:050 ShareWhiz InsightsGenerateNo content available.
